Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周三小幅收高。当内部人士购买或出售股票时,这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将其视为其整体投资或交易决策中的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多,请查看 本辛加的内幕交易 平台。
Carmell Therapeutics
卡梅尔治疗公司
- The Trade: Carmell Therapeutics Corporation (NASDAQ:CTCX) President and CEO Randolph W Hubbell acquired a total of 2,750 shares an average price of $3.67. To acquire these shares, it cost around $10,091.
- What's Happening: Carmell Therapeutics announced a merger with Axoloti Biologix.
- What Carmell Therapeutics Does: Carmell Therapeutics Corp is a regenerative medicine biotech company focused on leveraging our core platform technology, Plasma-based Bioactive Material to stimulate tissue repair or growth after injury, disease or aging.
- 交易: Carmell Therapeutics 纳斯达克股票代码:CTCX)总裁兼首席执行官 Randolph W Hubbell 共收购了2750股股票 平均价格为3.67美元。收购这些股票的成本约为10,091美元。
- 发生了什么: Carmell Therapeutics宣布与Axoloti Biologix合并。
- 卡梅尔治疗公司的工作: Carmell Therapeutics Corp是一家再生医学生物技术公司,专注于利用我们的核心平台技术,即基于等离子体的生物活性材料来刺激受伤、疾病或衰老后的组织修复或生长。
ClearOne
ClearOn
- The Trade: ClearOne, Inc. (NASDAQ:CLRO) 10% owner Edward D Bagley acquired a total of 5,171 shares at an average price of $0.84. The insider spent around $4,341.
- What's Happening: ClearOne posted a loss for the second quarter.
- What ClearOne Does: ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication.
- 这笔交易: ClearOne, Inc. 纳斯达克股票代码:CLRO)10% 的所有者 Edward D Bagley 共收购5,171股股票 平均价格为0.84美元。知情人士花费了约4,341美元。
- 发生了什么: ClearOne公布了第二季度的亏损。
- ClearOne 做什么: ClearOne Inc是一家通信解决方案公司,从事设计、开发和销售用于音频、视频和视觉通信的会议、协作、流媒体和数字标牌解决方案。
Design Therapeutics
设计疗法
- The Trade: Design Therapeutics, Inc. (NASDAQ:DSGN) Director Arsani William acquired a total of 2,235,000 shares at an average price of $2.40. To acquire these shares, it cost around $5.37 million. The company's other Director also bought 12,000 shares.
- What's Happening: Design Therapeutics reported initial results from its Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich ataxia.
- What Design Therapeutics Does: Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations.
- 这笔交易: Design Therapeutics, (纳斯达克股票代码:DSGN)董事阿萨尼·威廉 共收购了2,23.5万股股票 平均价格为2.40美元。收购这些股票的成本约为537万美元。该公司的另一位董事也购买了12,000股股票。
- 发生了什么: Design Therapeutics 报告了其用于治疗弗里德里希共济失调的 DT-216 的 1 期多剂量递增剂量研究的初步结果。
- 设计疗法的作用是什么: Design Therapeutics Inc是一家临床阶段的生物制药公司,从事GenetacTM分子的研发,GenetacTM分子是一类新型的小分子基因靶向嵌合体候选药物,旨在通过解决遗传性核苷酸重复扩张突变引起的疾病的根本原因来改善疾病。
Check This Out: Investor Optimism Improves Further As Investors Assess Economic Reports
看看这个: 随着投资者评估经济报告,投资者的乐观情绪进一步改善
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道
Telos
Telos
- The Trade: Telos Corporation (NASDAQ:TLS) Chairman and CEO John B Wood acquired a total of 90,402 shares at an average price of $2.05. The insider spent $185,026 to buy those shares.
- What's Happening: Telos was awarded a five-year contract with Defense Information Systems Agency.
- What Telos Does: Telos Corp offers technologically advanced, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated and pervasive threats.
- 这笔交易: Telos 公司 纳斯达克股票代码:TLS)董事长兼首席执行官 John B Wood 共收购了90,402股股票 平均价格为2.05美元。知情人士花费了185,026美元购买了这些股票。
- 发生了什么: Telos获得了与国防信息系统局签订的为期五年的合同。
- Telos 的所作所为: Telos Corp 提供技术先进、基于软件的安全解决方案,可增强和保护全球注重安全的组织免受快速演变、复杂和普遍存在的威胁。